Berlin Cures Holding AG | WebDisclosure

Basculer en Français

8295	Companies
114858	Keywords
55302	Articles
62445	Press releases

Headlines Articles Press releases Berlin Cures Holding AG

Home
Companies
Berlin Cures Holding AG

BRIEF

published on 04/03/2024 at 08:05, 7 months 18 days ago

Berlin Cures Boosts Research and Development with New Advisory Board

Biotechnology Advisory Board Long Covid Clinical Trial Berlin Cures
PRESS RELEASE

published on 04/03/2024 at 08:00, 7 months 18 days ago

Berlin Cures Expands Research Capabilities and Scientific Expertise with New Advisory Board
Berlin Cures appoints six renowned scientists to new advisory board to enhance research capabilities and support market launch of therapies, including for Long COVID

Advisory Board Long Covid Berlin Cures Scientists Research Capabilities
BRIEF

published on 03/04/2024 at 12:05, 8 months 17 days ago

Berlin Cures franchit une étape clé dans l’essai de phase II pour un traitement long contre le COVID

BC 007 Remèdes Berlinois Longue COVID Essai De Phase II Maladies Auto-immunes
BRIEF

published on 03/04/2024 at 12:05, 8 months 17 days ago

Berlin Cures Reaches Key Milestone in Phase II Trial for Long COVID Treatment

Long Covid Berlin Cures Phase II Trial BC 007 Autoimmune Diseases
PRESS RELEASE

published on 03/04/2024 at 12:00, 8 months 17 days ago

Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment
Berlin Cures reaches over 50% patient recruitment in Phase II trial for Long COVID treatment with BC 007, aiming to neutralize harmful autoantibodies. CEO emphasizes global impact and urgent need for innovative solutions

Long Covid Berlin Cures Phase II Trial Autoantibodies Innovative Treatment
PRESS RELEASE

published on 10/10/2023 at 08:30, 1 year 1 month ago

Berlin Cures takes next step in battle against Long COVID
PRESS RELEASE

published on 07/03/2023 at 09:00, 1 year 4 months ago

Berlin Cures starts Long COVID Phase II Trial – first patients admitted

Accesswire

Published on 11/21/2024 at 12:00, 36 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 36 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 6 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 33 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 36 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:15, 21 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 29 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 36 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 1 hour 6 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 35 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 28 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 16 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE